A B S T R A C T Plasma from an individual with a hereditary deficiency of kininogens is deficient in kininogen antigens; heterozygous relatives are partially deficient in plasma kininogen antigens. In addition, plasma from the proband is partially deficient in functional and antigenic properties of a plasma prekallikrein, and the relatives heterozygous for kininogen deficiency are also partially deficient in the plasma prekallikrein. It is possible that the defects are both inherited and that the inheritance of a deficiency of prekallikrein is genetically linked to the inheritance of a deficiency of kininogen. Alternatively, it is possible that the deficiency of prekallikrein may be due to its hypercatabolism which could be a consequence of a deficiency of high molecular weight kininogen that may stabilize the prekallikrein in plasma. Evidence to support this possibility is presented by the fact that prekallikrein and high molecular weight kininogen apparently exist as a complex in normal plasma, because monospecific antiserum to kininogen removed both high molecular weight kininogen and prekallikrein from plasma, and vice versa. Moreover, prekallikrein was not adsorbed from kininogen-deficient plasma by antiserum to kininogen unless high molecular weight kininogen was first added to the plasma. Low molecular weight kininogen did not participate in these reactions.
INTRODUCTION
In plasma from persons deficient in high molecular weight kininogen (HMW-HGN),1 surface-initiated reactions leading to the formation of clot-promoting activity, of kinins, fibrinolytic, permeability enhancing, and arginine esterase activity are all impaired (1) (2) (3) (4) (5) (6) . The markedly delayed clotting of plasma from persons deficient in plasma kininogens is not associated with a bleeding tendency (1) (2) (3) (4) (5) (6) . This coagulation defect can be corrected in vitro with preparations of HNIW-KGN whether the plasma is deficient only in certain species of kininogens including HMW-KGN, as in Fitzgerald trait (1, 2) , or in all species of kininogen molecules (3), as in Flaujeac (4) and Williams trait (5) . The deficiency called Reid trait (6) appears to reflect a partial deficiency of plasma kininogen in which HMW-KGN is deficient, and thus resembles Fitzgerald trait. 2 Deficiency of Fletcher factor (clot-promoting activity of a plasma prekallikrein) activity in Fitzgerald trait was observed (2, 3, 5, 6) , and the studies to be de-from Fisher Scientific Co., Pittsburgh, Pa.
Kininogens were isolated from normal human plasma at room temperature by modifications of published methods (5, (7) (8) (9) (10) . Blood was drawn into silicone-coated vessels containing 0.02 vol of 0.5 M citrate buffer, pH 5.2, hexadimethrine bromide to give a final concentration of50 ,ug/ml and EDTA to give a final concentration of 0.003 M. The plasma was separated during centrifugation at room temperature and made platelet-deficient by recentrifugation. Initially, 240 ml of plasma was diluted with 3 vol of distilled water and the pH adjusted to 6 with HCl. Then 30 g of DEAE- cellulose , which had been washed with water, 0.5 N sodium hydroxide, 0.5 N HC1, distilled water, and then with distilled water containing 50 ug/ml hexadimethrine bromide and 0.003 M EDTA was added while stirring at room temperature. After stirring for approximately 2 h, the cellulose was washed with 4-6 liters of distilled water containing hexadimethrine bromide and EDTA on a suction funnel, and crude kininogens were then eluted in 0.4 M sodium chloride. This kininogen-rich eluate was concentrated by lyophilization, dissolved in distilled water, dialyzed against 0.1 M Tris buffer, pH 8.0, and applied to a 2.5 x 60-cm column of QAE-Sephadex A-50 or of . After the column was washed with about 750 ml of the Tris buffer, kininogens were eluted with a linear gradient to 1.5 M sodium chloride in the Tris buffer and were identified by their capacity to release kinin after incubation with trypsin. Each pool of kininogen was concentrated by lyophilization, dissolved in distilled water, dialyzed against 0.03 M sodium acetate pH 5.8, and applied separately to a 2.5 x 30-cm column of CM-Sephadex C-50, already equilibrated with the sodium acetate. Kininogens were eluted with a linear gradient to 1.4 M sodium chloride in the acetate buffer, and fractions containing kininogen pooled and concentrated by precipitation in 60% ammonium sulfate. After thorough dialysis against 0.05 M Tris buffer, pH 8, the redissolved precipitates were applied to a 2.5 x 100-cm column of Sephadex G-150 equilibrated with pH 8.0, 0.05 M Tris. Fractions containing kininogen were pooled, and the materials soluble in solutions of 20%, but insoluble at 60% saturation with ammonium sulfate, were recovered, redissolved, and dialyzed thoroughly against Tris-glycine buffer, pH 9.0, used for polyacrylamide disk gel electrophoresis. Preparations of HMW-KGN used in experiments contained two bands of protein in analytical disc gel electrophoresis ( Fig.  1) , both of which contained Fitzgerald factor clotting activity and released kinin upon exposure to trypsin. Samples of the kininogens from G-150 which still contained other proteins were applied to 6 x 150-mm polyacrylamide disc gels and after electrophoresis at 5 mA per tube for 3 h, the gels were divided with an Autogeldivider into approximately 3-mm sections and each was eluted in pH 7.4 barbital saline buffer, and kininogen-containing fractions were pooled. After polyacrylamide particles were removed, these kininogens were exhaustively dialyzed against the barbital saline buffer. Two fractions containing HMW-KGN were identified by the release of kinin activity upon exposure to trypsin and because each contained Fitzgerald factor clotting activity. The anodal HMW-KGN was used in these experiments because there was a greater amount than in the cathodal fraction. The specific activity of the HMW-KGN prepared in this way was 4 ug bradykinin released/mg of protein by trypsin, but only 0.3 U of Fitzgerald factor activity/mg protein (1 U = the amount in 1 ml of normal plasma). The HMW-KGN shown in Fig. 1 All buffers used during the purification of kininogens contained hexadimethrine bromide, 50 ,ug/ml, and EDTA, 0.003 M, until the preparation was subjected to gel filtration on G-150 Sephadex. All procedures were carried out at room temperature except the precipitation with ammonium sulfate and the elution and dialysis of kininogens purified on polyacrylamide gels, which were carried out at 4°C.
Kallikrein was isolated from normal plasma which had been separated from blood drawn into 0.10 vol of 0.1 M sodium oxalate, according to a published method (11) . This plasma was adsorbed with tricalcium phosphate, 10 mg/ml, and the supematant fluid was adsorbed with 20 mg of Celite/ ml of plasma at room temperature. This Celite was washed with cold, distilled water until no visible precipitate occurred upon addition of an equal volume of 10% TCA to the wash. Crude kallikrein eluted from the Celite with 10% sodium chloride in pH 8 Tris buffer, 0.05 M, was passed over a lysine Sepharose column prepared according to the method of Deutsch and Mertz (12) for TAME esterase activity according to the method of Seigelman and associates (13) . This pool of concentrated kallikrein was purified during electrophoresis in 7% polyacrylamide disc gels at pH 9 for use as immunogen. One gel of each set was stained and the others sectioned and eluatesl in barbital saline buffer, pH 7.4, according to the proteins stained. Kallikrein activity was identified in those eluated by measuring their capacity to release kinin from normal plasma which had been heated at 61°C for 2 h, and measuring the kinin-releasing activity which was not inhibited by lima bean trypsin inhibitor. Antibody to kallikrein. Kallikrein-rich fractions eltuted from polyacrylamide disc gels were pooled, mixed with an equal volume of complete Freund's adjtuvant (Difco Laboratories, Detroit, Mich.), and injected into the foot pads of lightly anesthetized rabbits at weekly intervals, until the rabbit seruLm developed activity which blocked Fletcher factor clotting activity of normal human plasma. The serum obtained from rabbits at this time was absorbed with Fletcher trait plasma to render it monospecific; the adsorbed antiserum gave a single precipitin line when reacted with normal plasma in agarose gel, but no band of reaction with the Fletcher trait plasma. The monospecific antiserum was heated to 61°C for 2h, adsorbed with tricalcium phosphate, 10 mg/ml of seruLm. The gamma globulin fraction was isolated after adjustment of the pH of this serum to 4.8 with 0.1 M sodium acetate (pH 4). 1 vol of octanoic acid (Eastman Kodak Co., Rochester, N. Y.) was then added to each 10 vol of this pH 4.8 solution (14) . After centrifugation, the superuatant fluids were filtered through a Whatman no. 1 filter (Whatman Inc., Clifton N. J.) on a Buchner funnel, and the precipitate washed on this filter with about 50 ml of the pH 4 sodium acetate. The filtrates were combined, and the pH adjusted to 7.4 with 0.1 N sodium hydroxide, and the materials precipitated at 50% saturation with ammonium sulfate were recovered, dialyzed extensively against running water and then against barbital saline buffer. These precipitated antibody globtulins to kallikrein were used in experimental procedures.
Plasma prekallikrein and kallikrein were quantified immunologically with a rabbit antihuman prekallikrein which gave a precipitin reaction with both kallikrein and prekallikrein. A sensitive radioimmunoassay was used (15) to measure the low levels of prekallikrein in some of the stuLdies to be described. Plasma prekallikrein can be quantified at concentrations as low as 0.3% of the concentration found in normal pooled plasma with this assay.
Autibody to kininogent. This was prepared with mixtures of Prekallikrein and High Molecular Weight Kininogen FIGuRE 2 The center well contained sheep antibody to LMW-KGN from Dr. Jack Pierce. Contents of other wells from the top and clockwise: 1, normal human plasma; 2, goat antihuman kininogen prepared as described; 3, kininogen-deficient plasma; 4, Fitzgerald plasma; 5, goat antihuman kininogen as in 2; 6, kininogen-deficient plasma.
HMW-KGN that had been purified on polyacrylamide disc gels, mixed with an equal volume of complete Freund's adjuvant and residual polyacrylamide. These mixtures were injected intramuscularly into the back of a goat at weekly intervals until serum obtained could delay the clotting of normal plasma and deplete normal plasma of Fitzgerald factor clotting activity. This antibody was not monospecific, but after adsorption with kininogen-deficient plasma (3) , the antiserum was monospecific, and gamma globulin fractions were prepared just as for antibody to kallikrein. The monospecific antibody gave a reaction of complete identity with a sheep antibody to human LMW-KGN prepared by Dr. Jack Pierce, National Institutes of Health, Bethesda, Md., when these preparations were reacted against normal human plasma and Fitzgerald trait plasma in agarose gel double diffusion (Fig. 2) . When this antibody was reacted with the preparations of HMW-KGN and LMW-KGN in agarose gels, the precipitin reactions gave bands of complete identity between both kininogens and normal plasma (Fig. 3) , but no precipitin reaction with plasma from the proband deficient in all species of kininogen molecules described earlier (3) .
Protein concentrations in pu'rified reagents were determined by comparing optical density at 280 nm in a Gilford 240 spectrophotometer, with the optical densities of a standard curve of dilutions of a solution of a weighed amount of crystalline bovine serum albumin. Antibody globulins to kininogens and Fletcher factor kallikrein were coupled to Sepharose 4-B activated according to the method of March et al. (16) to provide insoluble antibody.
Specific assays for coagulant activities were carried out by testing the capacity of test solutions to correct the clotting defect of plasma from an individual with a severe inherited deficiency of the factor in question, using an activated partial thromboplastin time (17) and procedures detailed earlier (2) . Volumes of 50 ,ul of each reactant, instead of 100 /,l of each, were used in performing these assays. The percent of clotting activity was derived by comparing the clotting times of at least two dilutions of test plasma to a double logarithmic plot of the clotting times of four dilutions of a pool of 10 normal plasma samples. The buffer used in coagulation assays contained 2.76 g barbital, 2.06 g sodium barbital, and 7.3 g sodium chloride/liter.
Electroimmunodiffusion was carried out in 1% agarose gels containing antibody globulin to kininogen in a concentration of 3 ml/100 ml solution, using the procedure of Laurell (18) . Immunoelectrophoresis was carried out with a 1% agarose medium at pH 8.6 in barbital buffer containing calcium lactate (19) .
Tryptic digestion of kininogen containing fractions was carried out at pH 8 using 50 or 100 ,ug of trypsin/ml of 0.1 Tris buffer. The mixtures were incubated at 37°C for 30 min or more and an amount of soybean trypsin inhibitor, which slightly exceeded the amount of trypsin used, was added before assay. The assay for kinin activity was carried out at 29-31°C with a uterine horn from a rat in which estrus had been induced 18- Indianapolis, Ind.) in an 8-ml organ bath containing de Jalon's buffer (20) .
RESULTS
Monospecific goat antiserum to human kininogens gave precipitin reactions with both HMW-KGN and FIGuRE 3 Left: well 1 (top), kininogen-deficient plasma; well 2 (right), LMW-KGN; well 3 (lower), goat antihuman kininogen prepared as described; well 4 (left), HMW-KGN. Right: well 1, normal human plasma; wells 2, 3, and 4 as on the left. 574 Donaldson, Kleniewski, Saito, and Sayed LMW-KGN in agarose (Fig. 3) , indicating that these proteins share common antigenic determinants, as reported earlier (21) . The plasma from the proband deficient in kininogen gave no precipitin reaction with this antiserum, confirming our earlier report (3) that this plasma is deficient in all species of kininogen molecules. The antiserum gave reactions of complete identity between the kininogen preparations and normal human plasma (Fig. 3) , and in immunoelectrophoretic studies, two precipitin arcs of identical electrophoretic mobility were observed (Fig. 4) . It is likely that these arcs are due to kininogens of differing diffusability, perhaps because of differing molecular size or because of the existence of complexes between some plasma kininogens and other proteins such as prekallikrein (vide infra). Consistent with the latter possibility was the observation that a single precipitin arc was observed in the immunoelectrophoretic study of plasma from patient Fitzgerald (Fig. 4) Table II and Fig. 5 , for example. Plasma obtained from the proband at different times was essentially void of kininogen antigens (Fig. 5) as well as Fitzgerald factor clotting activity. Prekallikrein deficiency associated with hereditary kininogen deficiency. Samples of the proband's plasma obtained at different times contained from 12.5 to 35% of the normal amount of Fletcher factor clotting activity. Neither the deficiency of Fletcher factor nor Fitzgerald factor clotting activity could be attributed to an inhibitory property in plasma of the proband, for his plasma did not delay the clotting of normal plasma when the two were incubated together.
When plasma from other members of this kindred were tested for Fletcher factor clotting activity, each plasma which was partially deficient in kininogen contained less Fletcher factor activity than the mean value found in normal plasmas (Fig. 6 and Table I ). Although different plasma samples from the proband contained from 12.5 to 35% of the normal amount of Fletcher factor clotting activity, relatives who appeared to be heterozygous for kininogen deficiency had between 29 and 71% of the normal plasma concentrations of Fletcher factor activity (Table II) .
When prekallikrein antigen concentration was measured by a radial immunodiffusion technique (22) , its concentration in plasma from the proband was 71% of that in normal plasma which far exceeded the quantity of Fletcher factor activity. This could have been due to the presence of normal amounts of poorly functioning abnormal prekallikrein protein, or to a form of prekallikrein which contained more antigenic determinants than that in normal plasma. To confirm this discrepancy, the concentration of prekallikrein antigens in plasma from members of this kindred were determined with a sensitive radioimmunoassay (Table II, 
column 4).
In a sample from the proband, the concentration of Fletcher factor clotting activity was 35% of that in normal plasma, and the prekallikrein antigen concentration was 32% of normal. Thus, the concentrations of prekallikrein clotting activity and protein paralleled one another. In plasma from heterozygous members of the kindred, the Fletcher factor clotting activity ranged from 29 to 71% of normal (mean = 50.2+18%; P = <0.005; see Table II , column 2), and prekallikrein antigen concentration ranged from 62 to 92% of normal (mean = 75-+12.6%; P = <0.1). In most instances, there was a disproportionately high concentration of antigen. The significance ofthe difference between the clotting and antigen concentrations in the group of heterozygotes, however, is doubtful (P = <0.3, >0.2).
It was possible that this prekallikrein required HMW-KGN in order to function and that the deficiency of Fletcher factor activity was a manifestation of the kininogen deficiency. Therefore, the effect of kininogen upon the assay for Fletcher factor activity was Prekallikrein tested. When a highly pturified preparation of HMW-KGN was incubated with the proband's plasma before measuiring Fletcher factor activity, the amouint of Fletcher factor activity did not increase.
To determine whether deficient prekallikrein ftunction in this plasma was associated witlh a structural alteration of the molectule cauising a change in its net charge, plasma from the proband was examined by immuinoelectrophoresis with a monospecific rabbit antibody to human prekallikrein which gave a faint precipitin band when reacted against normal plasma in agarose. The prekallikrein precipitin arc in the kininogen-deficient plasma extended into a more cathodal region than that in normal plasma, but was a single arc. The addition of a preparation of HMW-KGN to this plasma before electrophoresis did not change the position of the precipitin arc; LMW-KGN also failed to change the position of this arc. When a mixture of equal parts of Fletcher trait plasma (containing normal amounts of kininogens) and plasma from the proband was examined in this way, the faint precipitin arc designating prekallikrein appeared to be in a more anodal position resembling that seen in normal plasma. Thus, the prekallikrein antigens in kininogen-deficient plasma appeared to have interacted with the HMW-KGN, or some other component of the Fletcher trait plasma so that it asstumed a normal electrophoretic mobility. The preparation of pturified HMW-KGN may have been partially denatured during its purification so that it did not interact with plasma prekallikrein uinder conditions of this procedure. Alternatively, another plasma substance may be involved.
Another approach that was used to identify the prekallikrein deficiency in kininogen-deficient plasma was to measure the p-toluene stilfonyl-L-arginine methyl esterase (TAME) activity which developed after exposure of plasma to kaolin. As reported earlier (1, 4, 5) , plasma markedly deficient in kininogen developed virttually no TAME esterase activity uipon exposure to kaolin. Plasma from heterozygous relatives, partially deficient in kininogen and in ftunctional prekallikrein, developed less esterase activity than did normal plasma so treated (Fig. 7 A) .
When purified preparations of HMW-KGN were added to the kininogen-deficient plasma before agitation with kaolin, the amount of TAME esterase activity which evolved after 10 min was increased but the increase apparent after about 1 min was insignificant ( Fig. 7 B) ; the early burst of esterase activity The Fletcher and Fitzgerald factor concentrations were determined in a coagulation assay and are expressed as a percent of the concentration in a pool of 10 normal plasmas.
The concentrations of kininogen shown were meastured immunologically by the method of Laurell (18) , as shown in Fig. 5 . The concentration of prekallikrein antigen w%as measured in a radioimmunoassay (15) . * Fletcher factor clotting activity of this sample was 35% of that of normal pool. MINUTES MIXED WITH KAOLIN FIGuRE 7 TAME esterase activity which evolved in plasmas during continuous agitation with kaolin was measured as methanol generated (13), shown on the ordinates. Mixtures of 0.15 ml of kaolin suspension (10 mg/ml of buffer) and 0.15 ml of plasma or mixtures of plasma and kininogens or buffer were agitated at room temperature for the time intervals shown on the abscissae and then 0.25 ml of TAME (42 mg/ml) was added and the mixtures transferred to a 37°C bath for 30-min incubation. Then, 1.0 ml of 10% TCA was added, and after 15 min or more at 4°C, the precipitates were removed by centrifugation, and methanol formation measured in the supernatant fluids as noted (13) . Incubation and assay mixtures were buffered with 0.1 M phosphate in 0.15 M sodium chloride at pH 7.4. A. Kaolin induced TAME hydrolysis in normal plasma, plasma from two individuals partially deficient in kininogen (heterozygotes) and the kininogen-deficient proband. B. The effect of adding 70 ,ug of HMW-KGN, 40 ,ug of LMW-KGN (measured as protein), or of equal parts of each KGN upon the TAME esterase activity of plasma from the kininogen-deficient proband. C. A comparison of the TAME esterase activity initiated by kaolin in normal, kininogen-deficient, and Fletcher trait plasmas with that which evolved in the mixtures shown. The mixture of normal and kininogen-deficient plasma contained 68% of the normal amount of Fletcher factor; the mixture of normal and Fletcher trait plasma contained about 50% of the normal amount of Fletcher factor, and equal parts kininogen-deficient and Fletcher trait plasma contained 16% of the Fletcher factor concentration in normal plasma.
found when normal plasma was treated with kaolin (11), apparently due largely to kallikrein, was not restored with this kininogen despite the fact that the amount of the kininogen preparation used shortened the clotting time of kininogen-deficient plasma from 400 to 50 s. Thus, the plasma behaved as if it were deficient in prekallikrein. A purified preparation of LMW-KGN, of even higher specific activity but similar protein concentration, did not correct defective kaolin-initiated TAME esterase activity in kininogendeficient plasma. When mixtures of HMW and LMW-KGN were added to this plasma, the increase in TAME esterase activity after 10 min agitation with kaolin was as would be predicted if this dilution of HMW-KGN alone were added to the plasma (Fig. 7 B) .
Surface-initiated TAME esterase activity was deficient in plasma mixtures which were partially deficient in Fletcher factor (Fig. 7 C) and in plasma from 578 Donaldson, Kleniewski, Saito, and Sayed heterozygous members of this kindred (Fig. 7 A) . The mixture of normal plasma and Fletcher trait plasma with significantly decreased esterase activity contained 50% of the normal concentration of prekallikrein; the mixture of normal and kininogendeficient plasma contained 68% of the normal amount of prekallikrein (Fig. 7 C) . When a mixture of equal parts of Fletcher trait and kininogen-deficient plasma was tested (Fig. 7 C) (Table III) . Conversely, antibody to kallikrein removed both Fletcher factor and Fitzgerald factor clotting activities from normal plasma (Table III) . Hageman factor and PTA activities were not removed by either procedure (Table III) . When insoluble antikininogen globulin complexed to agarose beads was used, the normal plasma was again depleted of both Fitzgerald and Fletcher factor clotting activities (Table III) clotting activities, suggesting that they may exist as a complex in the normal plasma. When kininogendeficient plasma from the proband was adsorbed with antibody to kininogen, the small amount of the Fletcher factor clotting activity present was not removed. When Fletcher trait plasma was adsorbed with antibody to kallikrein, the Fitzgerald factor clotting activity was not removed. Therefore, the depletion of both Fletcher and Fitzgerald factor clotting activities by antibody directed against either protein was not a nonspecific effect of the antibody globulins, or of the Sepharose.
The quantitative relationship between the amounts of Fitzgerald factor and of Fletcher factor activities removed from normal plasma with insoluble antikallikrein is shown in Fig. 8 activity, as well as the HMW-KGN which does have this activity (Fig. 3) . When a preparation of HMW-KGN was added to kininogen-deficient plasma, however, subsequent adsorption of the mixture with antikininogen resulted in depletion of the plasma of its prekallikrein (Table IV) (15) . The HMW-KGN used contained 60 ,ug of protein/ml (see Fig. 1 ). The kininogendeficient plasma contained 32% of the normal amount of prekallikrein antigen before dilution in assay mixtures.
gen antigens were also found in this eluate but only traces of Fletcher factor and Fitzgerald factor activities were identified. The concentrations of these clotting activities in the eluates did not parallel one another. The processes of elution and dialysis may have impaired the function of these proteins.
DISCUSSION
The antibody to human kininogens used in these studies reacted with both HMW-KGN and LMW-KGN and gave a single band of precipitation in an Ouchterloney analysis against normal plasma, but no precipitin band when reacted with kininogen-deficient plasma from the proband reported earlier (3 and Fig. 3) . Thus, it fulfills criteria for monospecificity. This antibody revealed two precipitin arcs of similar electrophoretic mobility when normal plasma and serum were subjected to immunoelectrophoretic analysis, but a single precipitin arc with plasma from patient Fitzgerald which contains kininogen that does not have clotting activity attributed to HMW-KGN (Fig. 4) . Thus, the antibody identifies antigenic determinants common to all species of kininogen molecules. With this antibody, the kininogen antigens in plasma from heterozygous members of the kindred with kininogen deficiency were quantified and found to be near half the amount found in normal plasma (Fig. 5 , Table II) , confirming our earlier report of partial deficiencies of functional kininogens in plasma from heterozygotes (3). In studies not illustrated, the concentrations of both HMW-KGN and LMW-KGN in plasma from a heterozygous member of this kindred were much less than in normal plasma when the two were compared with respect to their behavior during gel filtration on a column of G-200 Sephadex, and trypsin-released kinin measured. Both species of kininogen are apparently deficient in these individuals. Prekallikrein antigen was deficient in plasma from the proband in proportion to the deficiency of Fletcher factor clotting activity (Table II) . Relatives who were partially deficient in plasma kininogens were also partially deficient in Fletcher factor clotting activity, but in each instance the level of plasma prekallikrein antigens was not as low as the Fletcher factor activity (Table II) . The reasons for these differences are not clear, but the assay for Fletcher factor clotting activity is susceptible to variable influences, such as plasma inhibitors, which need not influence the radioimmunoassay for prekallikrein. Even so, the mean level of plasma prekallikrein antigens was below the normal (P = <0.1). The possibility that nonfunctional prekallikrein protein may exist in plasma from heterozygotes was .not entirely excluded.
The close relationship between prekallikrein and
